Thyroid Hormone in the Regulation of Neurotransmitter Function and Behaviour

  • Radhey L. Singhal
  • Ram B. Rastogi


Recent developments in the field of psychoneuroendocrinology have led to the suggestion that neuroendocrine strategies represent a useful approach for evalu­ating brain function during psychiatric illnesses. Studies have revealed that there are significant alterations in the levels of circulating hormones during affective disorders and psychoses. Since evidence also indicates that hormones affect the metabolism of putative neurotransmitters, it is likely that changes in the mental state during certain endocrine disorders might be the sequelae of alterations in the central monoamine metabolism produced by altered levels of hormones. Additionally, it has been shown that neurotransmitters such as catecholamines and indoleamine play a major role in the regulation of neuroendocrine function. Hence, it is important to determine which of the two abnormalities (i.e., changes in hormonal secretion induced by altered levels of central amines or aberrant metabolism of putative neurotransmitters induced by altered hormonal levels) has the prime role in the pathophysiology of these psychiatric illnesses.


Thyroid Hormone Antidepressant Action Spontaneous Alternation Spontaneous Locomotor Activity Neonatal Hypothyroidism 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Agarwal, R.A., Rastogi, R.B. and Singhal, R.L. (1977). Neuroendocrinology 23, 236 Balazs, R. (1971). Proc. Conf., 1969, 273Google Scholar
  2. Bartholini, G., Blum, J.E. and Pletscher, A. (1969). J. Pharm. Pharmacol., 21, 297 Beley, A., Beley, P. and Bralet, J. (1975). Arch. Int. Physiol. Biochem., 83, 471Google Scholar
  3. Bindler, E.H., Wallach, M.B. and Gershon, S. (1971). Arch. Int. Pharmacodyn. Ther., 190, 150 Broitman, S.T. and Donoso, A.O. (1971). Experientia 27, 1380Google Scholar
  4. Bursten, B. (1961). Arch. Gen. Psychiat., 4, 267Google Scholar
  5. Chase, T.N., Katz, R.I. and Kopin, I.J. (1970). Neuropharmacology 9, 103PubMedCrossRefGoogle Scholar
  6. Constantinidis, J., Gaillard, J.M., Hovaguimiam, T. and Tissot, R. (1974). Experientia 30, 1182PubMedCrossRefGoogle Scholar
  7. Corrodi, H., Fuxe, K., Lidbrink, P. and Olson, L. (1971). Brain Res., 29, 1PubMedCrossRefGoogle Scholar
  8. Costa, E., Guidotti, A., Mao, C.C. and Suria, A. (1975). Life Sci., 17, 167PubMedCrossRefGoogle Scholar
  9. Eayrs, J.T. (1960). Br. Med. Bull., 16, 122Google Scholar
  10. Emlen, W., Segal, D.S. and Mandell, A.J. (1972). Science 175, 79PubMedCrossRefGoogle Scholar
  11. Engstrom, G., Strombom, U. Svensson, T.H. and Waldeck, B. (1975). J. Neural. Trans., 37, 1 Evetts, K.D., Uretsky, N.J., Iversen, L.L. and Iversen, S.D. (1970). Nature 225, 961CrossRefGoogle Scholar
  12. Fieve, R.R. and Platman, S.R. (1968). Am. J. Psychiat., 125, 527PubMedGoogle Scholar
  13. Garcia-Argiz, C.A., Pasquini, J.M., Kaplun, B. and Gomez, C.J. (1967). Brain. Res., 6, 635 Gelber, S., Campbell, P.L., Deibler, G.E. and Sokoloff, L. (1964). J. Neurochem., 11, 221 Goodwin, F.K. and Sack, R.L. (1973). In Frontiers in Catecholamine Research, ed. E. Usdin and S. Snyder ( Pergamon Press, Oxford ) p. 1157Google Scholar
  14. Greenspan, K., Aronoff, M.A. and Bojdanski, D.F. (1970). Pharmacology 3, 129CrossRefGoogle Scholar
  15. 220.
    Thyroid Hormone and RegulationGoogle Scholar
  16. Hrdina, P.D., Gosh, P.K., Rastogi, R.B. and Singhal, R.L. (1975). Can. J. Physiol. Pharmacol., 53, 709Google Scholar
  17. Katz, R.I., Chase, T.N. and Kopin, I.J. (1968). Science 162, 466PubMedCrossRefGoogle Scholar
  18. Keller, H.H., Bartholini, G. and Pletscher, A. (1974). Nature 248, 529CrossRefGoogle Scholar
  19. Kleinschmidt, H.J., Waxenberg, S.E. and Cukor, R. (1956). J. Mt. Sinai Hosp. NY, 23, 131 Koranyi, L., Tamasy, V., Lissak, K., Kiraly, I. and Borsy, J. (1976). Psychopharmacology 49, 197Google Scholar
  20. Lapierre, Y.D., Rastogi, R.B. and Singhal, R.L. (1981). Gen. Pharmacol. (in press) Lazarus, J.H., Richards, A.R. and Addison, G.M. (1974). Lancet ii, 1160Google Scholar
  21. Lidz, T. and Whitehorn, J. (1949). J. Am. Med. Assoc., 139, 698Google Scholar
  22. Loosen, P.T., Prange, A.J., Jr. and Wilson, I.C. (1974). Arch. Gen. Psychiat., 36, 540 Maletzky, B. and Blachley, P. (1971). In The Use of Lithium in Psychiatry, ed. B. Maletzky and P.H. Blachley (CRC Press, Cleveland, Ohio ) p. 47Google Scholar
  23. Mason, J.W. (1975). In Emotions — Their Parameters and Measurement, ed. L. Levi ( Raven Press, New York ) p. 143Google Scholar
  24. Mason, J.W., Hartley, L.H. and Kotchen, T.A. (1973). J. Clin. Endocrinol. Metab., 14, 1567 Messiha, F.S., Agallianos, J. and Clower, C. (1970). Nature 225, 868Google Scholar
  25. Nicholson, J.L. and Altman, J. (1972). Brain Res., 44, 13PubMedCrossRefGoogle Scholar
  26. Patel, A.J., Lewis, P.D., Balazs, R., Bailey, P. and Lai, M. (1979). Brain Res., 172, 57 Perrild, H., Madsen, S.N. and Hansen, J.E.M. (1978). Brit. Med. J., 2, 1108Google Scholar
  27. Poitou, P. and Bohuon, C. (1975). J. Neurochem., 25, 535PubMedCrossRefGoogle Scholar
  28. Post, R.M., Kotin, J., Goodwin, F.K. and Gordon, E.K. (1973). Amer. J. Psychiat., 130, 67 Prange, A.J., Jr. and Wilson, I.C. (1972). Psychopharmacology 26, 82Google Scholar
  29. Prange, A.J., Jr., Wilson, I.C., Rabon, A.M. and Lipton, M.A. (1968). Excerpta Medica International Congress Series 180, 532Google Scholar
  30. Prange, A.J., Jr., Wilson, I.C., Rabon, A.M. and Lipton, M.A. (1969). Am. J. Psychiat., 126, 457PubMedGoogle Scholar
  31. Prange, A.J., Jr., Meek, J.L. and Lipton, M.A. (1970). Life Sci., 9, 901CrossRefGoogle Scholar
  32. Prange, A.J., Jr., Nemeroff, C.B., Lipton, M.A., Breese, C.R. and Wilson, I.C. (1978). In Handbook of Pharmacology, ed. L.L. Iversen, S.D. Iversen and S.H. Snyder ( Plenum Press, New York ) p. 1Google Scholar
  33. Rastogi, R.B. and Singhal, R.L. (1974a). Brain Res., 81, 253PubMedCrossRefGoogle Scholar
  34. Rastogi, R.B. and Singhal, R.L. (1974b). J. Pharmacol. Exp. Therap., 191, 72 Rastogi, R.B. and Singhal, R.L. (1976a). J. Pharmacol. Exp. Therap., 198, 609 Rastogi, R.B. and Singhal, R.L. (1976b). Life Sci., 18, 851Google Scholar
  35. Rastogi, R.B. and Singhal, R.L. (1977a). Can. J. Physiol. Pharmacol., 55, 490 Rastogi, R.B. and Singhal, R.L. (1977b). J. Pharmacol. Exp. Therap., 201, 92 Rastogi, R.B. and Singhal, R.L. (1978). Arch. Pharmacol., 304, 9Google Scholar
  36. Rastogi, R.B. and Singhal, R.L. (1979). Psychopharmacology 62, 287PubMedCrossRefGoogle Scholar
  37. Rastogi, R.B., Singhal, R.L. and Hrdina, P.D. (1975). Neuropharmacology 4, 747 Rastogi, R.B., Lapierre, Y.D. and Singhal, R.L. (1976a). J. Neurochem., 26, 443 Rastogi, R.B., Lapierre, Y.D. and Singhal, R.L. (1976b). J. Psychiat. Res., 13, 65 Rastogi, R.B., Agarwal, R.A., Lapierre, Y.D. and Singhal, R.L. (1977a). Eur. J. Pharmacol., 43, 91Google Scholar
  38. Rastogi, R.B., Hrdina, P.D., Dubas, T. and Singhal, R.L. (1977b). Brain Res., 123, 188 Rastogi, R.B., Lapierre, Y.D. and Singhal, R.L. (1979). J. Psychiat. Res., 15, 7Google Scholar
  39. Rastogi, R.B., Lapierre, Y.D. and Singhal, R.L. (1980a). Proceedings of the Second Annual Meeting of the Canadian College of Neuropsychopharmacology, Hamilton, April 26–7, 1979, p. 26Google Scholar
  40. Rastogi, R.B., Singhal, R.L. and Lapierre, Y.D. (1980b). Psychoparmacology, 72, 85 Rinieris, P., Christodonlou, G.N., Souvatzoglou, A., Koutras, D.A. and Stefani, C. (1980). Neuropsychobiol., 6, 29Google Scholar
  41. Schalock, R.L., Brown, W.J. and Smith, R.L. (1979). Developm. Psychobiol.,Schildkraut, J.J. Logue, M.A. and Doge, G.A. (1969). Psychopharmacologia 14, 135Google Scholar
  42. Schou, M., Amdisen, A., Eskajaer-Jensen, S. and Olsen, T. (1968). Brit. Med. J., D.S., Callaghan, M. and Mandell, A.J. (1975). Nature 254, 58CrossRefGoogle Scholar
  43. Shopsin, B., Blum, M. and Gershon, S. (1969). Comp. Psychiat., 10, 215CrossRefGoogle Scholar
  44. Singhal, R.L. and Rastogi, R.B. (1978). Adv. Pharmacol. Chemother., 15, 203 Smith, D.F. (1976). Pharmacol. Res. Comm., 8, 575Google Scholar
  45. Smith, D.F. (1976). PharmacoL Res. Comm., 8 575Google Scholar
  46. Sobrian, S.K., Pappas, B.A., Edson, N., Rastogi, R. and Singhal, R.L. (1976). Res. Comm. Psycho!. Psychiat. Behay., 3, 419Google Scholar
  47. Stein, L., Wise, C.D. and Belluzzi, J.D. (1975). In Mechanism of Action of Benzodiazepines, ed. E. Costa and P. Greengard ( Raven Press, New York ) p. 29Google Scholar
  48. Svensson, T.H. (1976). Proceedings of Tenth Congress of College of International Neuropsychopharmacology, p. 104Google Scholar
  49. Tata, J.R., Ernster, L., Lindberg, O., Arrhenims, E., Pedersen, S. and Hedman, R. (1963). Biochem. J., 86, 408PubMedGoogle Scholar
  50. Toth, S. and Csaba, B. (1966). Experientia 22, 755CrossRefGoogle Scholar
  51. Transbol, I., Christiansen, C. and Baastrup, P.C. (1978). Acta Endocr., 87, 759 Weichsel, M.E. (1974). Brain Res., 78, 455Google Scholar
  52. Wheatley, D. (1972). Arch. Gen. Psychiat., 26, 229Google Scholar

Copyright information

© Pavel D. Hrdina and Radhey L. Singhal 1981

Authors and Affiliations

  • Radhey L. Singhal
  • Ram B. Rastogi

There are no affiliations available

Personalised recommendations